Those determined to outshine the market strategically focus on the selection of individual stocks. Well-chosen stocks have the potential to substantially boost your wealth.
As of close of business last night, Adaptive Biotechnologies Corp’s stock clocked out at $2.40, up 2.78% from its previous closing price of $2.34. In other words, the price has increased by $2.78 from its previous closing price. On the day, 2.34 million shares were traded. ADPT stock price reached its highest trading level at $2.4798 during the session, while it also had its lowest trading level at $2.28.
Ratios:
To gain a deeper understanding of ADPT’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 4.50 and its Current Ratio is at 4.66. In the meantime, Its Debt-to-Equity ratio is 0.74 whereas as Long-Term Debt/Eq ratio is at 0.71.
On January 05, 2023, Scotiabank started tracking the stock assigning a Sector Outperform rating and target price of $15.
Piper Sandler Upgraded its Neutral to Overweight on December 21, 2022, whereas the target price for the stock was revised from $7.50 to $14.
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 05 ’24 when ROBINS CHAD M sold 48,673 shares for $3.43 per share. The transaction valued at 167,007 led to the insider holds 2,576,701 shares of the business.
RUBINSTEIN JULIE sold 39,070 shares of ADPT for $135,764 on Mar 05 ’24. The President now owns 472,754 shares after completing the transaction at $3.47 per share. On Mar 05 ’24, another insider, BENZENO SHARON, who serves as the Chief Commercial Ofc Imm Med of the company, sold 29,390 shares for $3.44 each. As a result, the insider received 100,994 and left with 327,415 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADPT now has a Market Capitalization of 348220800 and an Enterprise Value of 231131456. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.04 while its Price-to-Book (P/B) ratio in mrq is 1.13. Its current Enterprise Value per Revenue stands at 1.357 whereas that against EBITDA is -1.289.
Stock Price History:
Over the past 52 weeks, ADPT has reached a high of $9.08, while it has fallen to a 52-week low of $2.33. The 50-Day Moving Average of the stock is -29.18%, while the 200-Day Moving Average is calculated to be -50.61%.
Shares Statistics:
It appears that ADPT traded 1.64M shares on average per day over the past three months and 2478830 shares per day over the past ten days. A total of 145.08M shares are outstanding, with a floating share count of 138.51M. Insiders hold about 4.54% of the company’s shares, while institutions hold 98.12% stake in the company. Shares short for ADPT as of 1711584000 were 9096668 with a Short Ratio of 5.53, compared to 1709164800 on 8767196. Therefore, it implies a Short% of Shares Outstanding of 9096668 and a Short% of Float of 8.04.
